Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis
Open Access
- 6 March 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 18 (1), 1-9
- https://doi.org/10.1186/s12879-018-3033-9
Abstract
Background: Drug resistant tuberculosis (TB) is increasing in prevalence worldwide. Treatment failure and relapse is known to be high for patients with isoniazid resistant TB treated with standard first line regimens. However, risk factors for unfavourable outcomes and the optimal treatment regimen for isoniazid resistant TB are unknown. This cohort study was conducted when Vietnam used the eight month first line treatment regimen and examined risk factors for failure/relapse among patients with isoniazid resistant TB. Methods: Between December 2008 and June 2011 2090 consecutive HIV-negative adults (>= 18 years of age) with new smear positive pulmonary TB presenting at participating district TB units in Ho Chi Minh City were recruited. Participants with isoniazid resistant TB identified by Microscopic Observation Drug Susceptibility (MODS) had extended follow-up for 2 years with mycobacterial culture to test for relapse. MGIT drug susceptibility testing confirmed 239 participants with isoniazid resistant, rifampicin susceptible TB. Bacterial and demographic factors were analysed for association with treatment failure and relapse. Results: Using only routine programmatic sputum smear microscopy for assessment, (months 2, 5 and 8) 30/239 (12. 6%) had an unfavourable outcome by WHO criteria. Thirty-nine patients were additionally detected with unfavourable outcomes during 2 year follow up, giving a total of 69/239 (28.9%) of isoniazid (INH) resistant cases with unfavourable outcome by 2 years of follow-up. Beijing lineage was the only factor significantly associated with unfavourable outcome among INH-resistant TB cases during 2 years of follow-up. (adjusted OR = 3.16 [1.54-6.47], P = 0.002). Conclusion: One third of isoniazid resistant TB cases suffered failure/relapse within 2 years under the old eight month regimen. Over half of these cases were not identified by standard WHO recommended treatment monitoring. Intensified research on early identification and optimal regimens for isoniazid resistant TB is needed. Infection with Beijing genotype of TB is a significant risk factor for bacterial persistence on treatment resulting in failure/relapse within 2 years. The underlying mechanism of increased tolerance for standard drug regimens in Beijing genotype strains remains unknown.Keywords
Funding Information
- Wellcome Trust (081814/Z/06/Z)
This publication has 27 references indexed in Scilit:
- Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2016
- Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2010
- Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysisPLoS Medicine, 2009
- The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam.2009
- Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysisAnnals of Internal Medicine, 2008
- The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosisPLoS Pathogens, 2008
- Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with Human Immunodeficiency Virus Infection and Multidrug Resistance in Cases of Tuberculous MeningitisJournal of Clinical Microbiology, 2006
- Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TBNew England Journal of Medicine, 2006
- Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The NetherlandsClinical Microbiology & Infection, 2006
- Mutations at Amino Acid Position 315 of thekatGGene Are Associated with High‐Level Resistance to Isoniazid, Other Drug Resistance, and Successful Transmission ofMycobacterium tuberculosisin The NetherlandsThe Journal of Infectious Diseases, 2000